Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to -$94.6 million.

  • IDEAYA Biosciences' Consolidated Net Income rose 3438.93% to -$94.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.9 million, marking a year-over-year increase of 10424.56%. This contributed to the annual value of -$159.3 million for FY2025, which is 5127.67% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Consolidated Net Income stood at -$94.6 million for Q4 2025, which was up 3438.93% from $108.5 million recorded in Q3 2025.
  • IDEAYA Biosciences' 5-year Consolidated Net Income high stood at $108.5 million for Q3 2025, and its period low was -$144.1 million during Q4 2024.
  • Moreover, its 5-year median value for Consolidated Net Income was -$26.4 million (2022), whereas its average is -$31.1 million.
  • In the last 5 years, IDEAYA Biosciences' Consolidated Net Income tumbled by 517969.7% in 2023 and then surged by 26212.76% in 2025.
  • IDEAYA Biosciences' Consolidated Net Income (Quarter) stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then skyrocketed by 34.39% to -$94.6 million in 2025.
  • Its Consolidated Net Income was -$94.6 million in Q4 2025, compared to $108.5 million in Q3 2025 and -$144.1 million in Q4 2024.